Literature DB >> 11802755

Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

Nicholas L Smith1, Joshua I Barzilay, Douglas Shaffer, Peter J Savage, Susan R Heckbert, Lewis H Kuller, Richard A Kronmal, Helaine E Resnick, Bruce M Psaty.   

Abstract

BACKGROUND: The contributions of fasting and 2-hour postchallenge glucose level to cardiovascular events remain ill-defined, especially for nondiabetic adults. This study examined the relative predictive power of fasting and 2-hour glucose level on cardiovascular event risk.
METHODS: A total of 4014 community-dwelling adults 65 years or older who participated in the baseline visit of the Cardiovascular Health Study and who were without treated diabetes or previous myocardial infarction or stroke were eligible for analyses. Participants with treated diabetes at baseline were excluded. Incident myocardial infarction or stroke, or coronary death, was the outcome of interest. Age-, sex-, and race-adjusted proportional hazards regression models described individual and joint associations between baseline measures of fasting and 2-hour postchallenge glucose level and event risk.
RESULTS: There were 764 incident cardiovascular events during 8.5 years of follow-up. Fasting glucose level of 115 mg/dL (6.4 mmol/L) or more was associated with an increased cardiovascular risk (hazard ratio [HR], 1.66 [95% confidence interval (CI), 1.39-1.98]) in adjusted analyses compared with fasting glucose level less than 115 mg/dL. Two-hour glucose level was associated with a linear risk (HR, 1.02 [95% CI, 1.00-1.04] per 10 mg/dL [0.6 mmol/L]) that included an additional increase in risk for 2-hour glucose level of 154 mg/dL (8.5 mmol/L) or more (HR, 1.29 [95% CI, 1.04-1.59]) in adjusted analyses. In joint fasting and 2-hour glucose models, only 2-hour glucose level remained predictive of event risk.
CONCLUSIONS: Two-hour glucose level was better than fasting glucose level alone at identifying older adults at increased risk of major incident cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802755     DOI: 10.1001/archinte.162.2.209

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  44 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

2.  Associations of 1,5-Anhydroglucitol and 2-Hour Glucose with Major Clinical Outcomes in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Bethany Warren; Alexandra K Lee; Christie M Ballantyne; Ron C Hoogeveen; James S Pankow; Morgan E Grams; Anna Köttgen; Elizabeth Selvin
Journal:  J Appl Lab Med       Date:  2020-11-01

3.  Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.

Authors:  Erika F Brutsaert; Sanyog Shitole; Mary Lou Biggs; Kenneth J Mukamal; Ian H deBoer; Evan L Thacker; Joshua I Barzilay; Luc Djoussé; Joachim H Ix; Nicholas L Smith; Robert C Kaplan; David S Siscovick; Bruce M Psaty; Jorge R Kizer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-27       Impact factor: 6.053

Review 4.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

5.  Association of levels of fasting glucose and insulin with rare variants at the chromosome 11p11.2-MADD locus: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.

Authors:  Belinda K Cornes; Jennifer A Brody; Naghmeh Nikpoor; Alanna C Morrison; Huan Chu; Byung Soo Ahn; Shuai Wang; Marco Dauriz; Joshua I Barzilay; Josée Dupuis; Jose C Florez; Josef Coresh; Richard A Gibbs; W H Linda Kao; Ching-Ti Liu; Barbara McKnight; Donna Muzny; James S Pankow; Jeffrey G Reid; Charles C White; Andrew D Johnson; Tien Y Wong; Bruce M Psaty; Eric Boerwinkle; Jerome I Rotter; David S Siscovick; Robert Sladek; James B Meigs
Journal:  Circ Cardiovasc Genet       Date:  2014-06

Review 6.  Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Authors:  Nadeem Sarwar; Thor Aspelund; Gudny Eiriksdottir; Reeta Gobin; Sreenivasa Rao Kondapally Seshasai; Nita G Forouhi; Gunnar Sigurdsson; John Danesh; Vilmundur Gudnason
Journal:  PLoS Med       Date:  2010-05-25       Impact factor: 11.069

7.  Association between physical performance and all-cause mortality in CKD.

Authors:  Baback Roshanravan; Cassianne Robinson-Cohen; Kushang V Patel; Ernest Ayers; Alyson J Littman; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Leslie I Katzel; Bryan Kestenbaum; Stephen Seliger
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

8.  Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50.

Authors:  Y Gao; G Li; Y Li; X Guo; G Yuan; Q Gong; L Yan; Y Zheng; J Zhang
Journal:  Int J Clin Pract       Date:  2008-07-24       Impact factor: 2.503

9.  Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.

Authors:  Paul G H Janssen; Kees J Gorter; Ronald P Stolk; Mehmet Akarsubasi; Guy E H M Rutten
Journal:  BMC Fam Pract       Date:  2008-12-16       Impact factor: 2.497

10.  Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study.

Authors:  Clara Kelliny; Ulf Ekelund; Lars Bo Andersen; Soren Brage; Ruth J F Loos; Nicholas J Wareham; Claudia Langenberg
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.